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Background: Exposure to arsenic via drinking water is a significant environmental issue affecting millions of people
around the world. Exposure to arsenic during foetal development has been shown to impair somatic growth and
increase the risk of developing chronic respiratory diseases. The aim of this study was to determine if in utero
exposure to low dose arsenic via drinking water is capable of altering lung growth and postnatal lung mechanics.
Methods: Pregnant C57BL/6 mice were given drinking water containing 0, 10 (current World Health Organisation
(WHO) maximum contaminant level) or 100μg/L arsenic from gestational day 8 to birth. Birth outcomes and
somatic growth were monitored. Plethysmography and the forced oscillation technique were used to collect
measurements of lung volume, lung mechanics, pressure-volume curves and the volume dependence of lung
mechanics in male and female offspring at two, four, six and eight weeks of age.
Results: In utero exposure to low dose arsenic via drinking water resulted in low birth weight and impaired
parenchymal lung mechanics during infancy. Male offspring were more susceptible to the effects of arsenic on
growth and lung mechanics than females. All alterations to lung mechanics following in utero arsenic exposure
were recovered by adulthood.
Conclusions: Exposure to arsenic at the current WHO maximum contaminant level in utero impaired somatic
growth and the development of the lungs resulting in alterations to lung mechanics during infancy. Deficits in
growth and lung development in early life may contribute to the increased susceptibility of developing chronic
respiratory disease in arsenic exposed human populations.
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Arsenic is a toxic metalloid that contaminates drinking
water through both natural and anthropogenic sources
[1]. Millions of people around the world are exposed to ar-
senic in drinking water at levels above the current World
Health Organisation (WHO) maximum contaminant level
(MCL) of 10μg/L [2,3]. Several studies have established
the link between arsenic exposure and increased lung can-
cer risk; however, emerging data suggest an important role
for arsenic in non-malignant lung disease. Epidemiological
data have linked arsenic exposure via drinking water to
chronic cough [4], chronic bronchitis [5], bronchiectasis* Correspondence: kramsey@ichr.uwa.edu.au
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reproduction in any medium, provided the or[6] and obstructive lung diseases [7]. Ingestion of arsenic
in drinking water has also been associated with respiratory
symptoms such as shortness of breath and morning cough
[8], and decrements in lung function, including reduced
FEV1 (forced expiratory volume in 1 s) and reduced forced
vital capacity [8-10].
Of particular concern, is the mounting evidence that
exposure to arsenic in foetal or early postnatal life has
the greatest effect on respiratory health. Exposure to ar-
senic in utero, through maternal drinking water, has
been shown to alter the expression of genes in the lungs
at birth in rats [11], and result in the development of
pulmonary tumours in adult mice [12]. Following a
discrete exposure event in Antofagasta, Chile in the
1950-1970s, it was found that exposure to arsenic in
utero and early postnatal life resulted in a standardised
mortality ratios for bronchiectasis in young adults ofl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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3.3–31.7) if the exposure only occurred postnatally [13].
These data suggest that early life exposure to arsenic can
have profound effects on lung health decades after the
exposure event.
Exposure to environmental toxins in utero may have sig-
nificant effects on growth and organ development, and
have long term implications for disease risk [14]. Arsenic
is a known transplacental toxin which is able to cross the
placenta and enter foetal circulation at levels equivalent to
maternal circulation [15]. In contrast, low levels of arsenic
are excreted in the breast milk and breastfeeding is
thought to be protective in arsenic exposed areas [16]. In
arsenic exposed areas of Bangladesh and West Bengal,
exposure to arsenic during pregnancy is associated with
infants being born small for gestational age [17] and at a
greater risk of developing lower respiratory tract infections
in infancy [18]. A mouse study investigating the effects of
in utero and postnatal exposure to arsenic, at the current
WHO MCL of 10μg/L, found that exposed offspring had
significant deficits in growth after birth compared with
unexposed offspring [19], highlighting the potency of ar-
senic as an early life toxicant.
Exposure to arsenic during the critical window of de-
velopment in foetal life may not just restrict growth, but
also impair development of the lungs [20]. Foetal growth
restriction is associated with worse lung function and
greater respiratory morbidity in early childhood [21-23]
and adulthood [24,25]. In this study, we determined the
effects of in utero exposure to low dose arsenic on som-
atic growth, lung growth and lung mechanics using a
mouse model. We hypothesised that in utero arsenic
exposure would alter the growth and development of
the lungs resulting in impairments to postnatal lung
mechanics.
Methods
Animals and exposure protocol
Time-mated C57BL/6 dams (Animal Resource Centre;
Murdoch, Western Australia) were housed at the Telethon
Institute for Child Health Research with a 12 h: 12 h light/
dark cycle. All experiments were conducted with the ap-
proval of the Telethon Institute for Child Health Research
Animal Ethics Committee and conformed to the guidelines
of the National Health and Medical Research Council of
Australia. Dams were given drinking water containing 0
(control), 10 or 100μg/L arsenic in the form of soluble
sodium arsenite (NaAs2O3). This water was provided
ad libitum from day 8 gestation to delivery (~ day 20 gesta-
tion) which ensured that the foetus was exposed to arsenic
prior to the development of the lung buds (e9) [26].
Concentrations of arsenic in drinking water were con-
firmed by inductively coupled plasma-mass spectro-
metry (ICP-MS; Geotechnical Services, Western Australia).Maternal water consumption, gestation period and litter
size were recorded along with somatic growth (body weight
and snout-vent length) at birth and the day lung function
measurements were taken. Lung function was assessed in
male and female offspring at two, four, six and eight weeks
of age.
Animal preparation
Mice were anaesthetised by intraperitoneal injection of a
mixture containing xylazine (2mg/mL; Troy Laboratories,
New South Wales, Australia) and ketamine (40mg/mL;
Troy Laboratories, New South Wales, Australia) at a dose
0.1mL/10g body weight. Mice were tracheotomised and a
tracheal cannula inserted (23G stainless steel for two and
four week old mice; 1.26 mm outer diameter polyethylene
tube for six and eight week old mice) and secured with su-
ture. Mice were ventilated (MiniVent, Harvard Apparatus,
Germany) at a tidal volume of 8mL/kg, respiratory rate of
400 breaths per minute and positive end expiratory pres-
sure of 2 cmH2O. This elevated respiratory rate was used
to suppress spontaneous breathing thus allowing the
apnoeic periods required for measurement of lung func-
tion without the need for paralysis.
Thoracic gas volume
Plethysmography was used to measure thoracic gas volume
(TGV) as described previously [27]. Briefly, the trachea
was occluded at end expiration (transrespiratory pressure,
Prs = 0 cmH2O) and the intercostal muscles were
stimulated with intramuscular electrodes to induce inspira-
tory efforts. Six 20V pulses of 2-3ms in duration were
delivered over a 6s period while recording changes in tra-
cheal pressure and plethysmograph box pressure. TGV was
calculated using Boyle’s law after correcting for the imped-
ance and thermal properties of the plethysmograph [27].
Baseline lung mechanics
Lung mechanics were measured using the forced-
oscillation technique as described previously [28]. The for-
cing function (9 frequencies from 4 – 38 Hz) was
generated by a loudspeaker and delivered to the animal via
a wave tube during pauses in ventilation. The respiratory
system impedance spectrum (Zrs) was measured and a
4-parameter model with constant phase tissue impedance
was fitted to the data to partition Zrs into components
representing the mechanical properties of the airways and
parenchyma [29]. This model allowed the calculation of
airway resistance (Raw) and inertance (Iaw) and coefficients
of tissue damping (G) and elastance (H). The resistance
and inertance of the tracheal cannula were subtracted
from Raw and Iaw respectively. As most of the inertance is
contained in the tracheal cannula, values of Iaw were insig-
nificant and are not reported.
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The volume dependence of lung mechanics was assessed
during a slow inflation-deflation (ID) manoeuvre from 0
to 20 cmH2O Prs. Inspiration was induced by applying a
controlled negative pressure to the plethysmograph and
expiration was achieved by the slow equilibration of the
plethysmograph to atmospheric pressure through a
resistor. During the manoeuvre, an oscillatory signal was
applied to the lung as described above. The 4-parameter
model was fitted to the Zrs using 0.5s data epochs
extracted from the signal during the recording period.
By monitoring plethysmograph pressure, integrating
flow and calculating starting TGV we were also able to
construct absolute pressure-volume curves.
Experimental protocol
To establish a volume history two ID manoeuvres were
performed separated with 5 min of regular ventilation.
Two measurements of TGV were recorded followed by
6 measurements of baseline lung mechanics at 0 cmH2O
Prs. TGV was recorded again before a final ID manoeuvre
(used for analyses).
Statistical analysis
Maternal and birth outcome means were compared by
one-way ANOVA using GraphPad Prism (Version 5.02,
GraphPad Software, San Diego, CA USA). Somatic
growth, TGV and lung mechanics within each sex were
analysed by two-way ANOVA using Sigma Plot with
Holm-Sidak post-hoc analysis (Version 11.0, Systat Soft-
ware, Chicago, IL USA). A p value of less than 0.05 was
considered significant.
Results
Effects of exposure to arsenic on maternal, birth and
growth outcomes
There was no difference in the amount of water consumed
per day between dams exposed to either concentration of
arsenic or control water (p = 0.57), nor were there any
differences in litter size (p = 0.45) or gestational period
(p = 0.32) between arsenic and control water exposed
mice (Table 1). At birth, offspring exposed in utero toTable 1 Maternal and birth outcomes for C57BL/6J dams exp
water (mean ± SD)
Control
Maternal water consumption (mL/day) 5.11 ± 1.41
Gestation period (days) 20.1 ± 0.92
Litter size (pups/dam) 5.63 ± 1.98
Birth weight (g) 1.34 ± 0.16
Birth length (mm) 29.1 ± 1.74
There were no differences in maternal water consumption, gestation period or litte
L arsenic were born significantly smaller than control mice in both weight and leng100μg/L arsenic were significantly smaller in weight
(p < 0.001) and length (p < 0.001) than controls, but there
were no differences in birth weight or length between
offspring exposed to 10μg/L arsenic and controls (p > 0.47)
(Table 1). The number of offspring tested from each expos-
ure group at each age is shown in Table 2. There was no ef-
fect of in utero arsenic exposure on body weight in male
(p > 0.58) or female (p > 0.22) offspring at two, four, six or
eight weeks of age. Likewise, there was no effect of arsenic
on TGV in males (p > 0.30) or females (p > 0.57) at any
age (Figure 1).
Effects of in utero exposure to arsenic on early life lung
mechanics
Two week old male offspring exposed to 10μg/L and
100μg/L arsenic had higher tissue damping (p < 0.001)
and tissue elastance (p < 0.001) compared to male
controls (Figure 2). Two week old male offspring exposed
to 10μg/L arsenic had lower airway resistance (p = 0.03)
compared to male controls (Figure 2). There were no
differences in airway resistance between two week old
male mice exposed to 100μg/L arsenic and male controls
(p > 0.42). Although female mice showed similar trends in
the data as males, there were no significant effects of ar-
senic on parenchymal lung mechanics (G, p = 0.31; H,
p = 0.64) or airway resistance (Raw, p = 0.14) in two week
old female offspring exposed in utero to 10 or 100μg/L
arsenic via drinking water (Figure 2).
The maximum TGV reached during inflation to Prs =
20 cmH20 was significantly lower in two week old male
offspring exposed to 100μg/L arsenic (p = 0.02) compared
to male controls (Figure 3). Exposure to arsenic at 10μg/L
in utero had no effect on maximum TGV during inflation
in two week old males (p > 0.95 in all cases). There were
no significant effects of arsenic, at either dose, on max-
imum TGV at Prs = 20 cmH20 in two week old female
offspring (p > 0.41 in both cases) (Figure 3).
Two week old male offspring exposed to 100μg/L ar-
senic had significantly higher tissue elastance and tissue
damping at Prs = 20 cmH20 compared to male controls
(H p = 0.02; G p = 0.03, Figure 4). Exposure to arsenic
at 10μg/L in utero had no effect on tissue elastance orosed to 0 (control), 10 or 100μg/L arsenic via drinking
10μg/L As 100μg/L As
4.97 ± 1.36 4.91 ± 1.33
20.4 ± 0.88 20.0 ± 0.81
4.79 ± 1.87 5.54 ± 2.23
1.35 ± 0.19 1.27 ± 0.18 *
28.8 ± 1.94 28.4 ± 1.90 *
r size between control and arsenic exposed mice. Offspring exposed to 100μg/
th (* indicates significantly different to controls).
Table 2 Numbers of offspring tested at each age from
each exposure group.
Numbers of offspring tested Control 10μg/L As 100μg/L As
2 weeks - males 24 11 23
2 weeks - females 25 13 15
4 weeks - males 22 9 7
4 weeks - females 13 9 9
6 weeks - males 14 7 24
6 weeks - females 14 4 11
8 weeks - males 17 5 12
8 weeks - females 17 9 12
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(G and H, p > 0.33). There were no differences in airway
resistance at Prs = 20 cmH20 between two week old male
offspring exposed to arsenic and control water (p > 0.21 in
all cases, Figure 3). Exposure to arsenic at 10 or 100μg/L
in utero had no effect on parenchymal mechanics (G or
H, p > 0.54) or airway resistance (Raw p > 0.30, in all cases)
at Prs = 20 cmH20 in females at two weeks (Figure 4).
Effects of in utero exposure to on lung mechanics
throughout life
There were no significant effects of arsenic on tissue
damping (p > 0.31) or tissue elastance (p > 0.61, Figure 5)
in male or female offspring at 4, 6 or 8 weeks of age.
There were also no effects of arsenic on airway resistanceFigure 1 Body weight and thoracic gas volume in two, four, six and e
utero to drinking water containing 0 (control), 10 or 100μg/L arsenic
volume between offspring exposed to arsenic and controls at two, four, six(p > 0.34) in either male or female offspring at 4, 6 or 8
weeks of age (data not shown). There were no effects of
arsenic maximum TGV at Prs = 20 cmH20 in male or
female offspring at 4, 6 or 8 weeks of age compared to
controls (p > 0.47 in all cases, data not shown). There
were also no effects of arsenic on airway or parenchymal
mechanics at Prs = 20 cmH20 in male or female offspring
at 4, 6 and 8 weeks of age (p > 0.21 in all cases, data
not shown).
Discussion
In this study a brief exposure of pregnant mice to envi-
ronmentally low doses of arsenic altered in utero growth
and lung development of their offspring resulting in
deficits in postnatal lung mechanics. This is the first
study to show that in utero exposure alone to low doses
of arsenic via drinking water is capable of impairing
postnatal lung function. Exposure to the current WHO
MCL of 10μg/L arsenic significantly impaired lung func-
tion suggesting that the current MCL may fail to protect
against the non-malignant effects of arsenic on the lung.
The lung mechanics of male mice were impaired more
than those of female mice indicating that males may be
more susceptible to the adverse effects of arsenic on the
lungs. These deficits in lung mechanics were evident in
early life but resolved with age.
Arsenic exposure had a direct effect on in utero
growth in male offspring exposed to 100μg/L resulting
in lower birth weight and length in males compared withight week old male and female C57BL/6 offspring exposed in
(mean). There were no differences in body weight or thoracic gas
or eight weeks of age.
Figure 2 Airway resistance, tissue damping and tissue elastance at Prs = 0 cmH20 in two week old male and female C57BL/6 offspring
exposed in utero to drinking water containing 0 (control), 10 or 100μg/L arsenic (mean ± SD). Tissue damping and tissue elastance were
higher in two week old male offspring exposed to 10 or 100μg/L arsenic compared with controls. There was no effect of arsenic, at either dose,
on lung mechanics in two week female offspring (* indicates significantly different to controls).
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age at birth between offspring exposed to arsenic
compared with controls. These mice were therefore
small for gestational age, indicating that arsenic expos-
ure in utero caused intrauterine growth restriction. Simi-
larly in epidemiological studies, exposure to low dose
(<100μg/L) arsenic during pregnancy was linked to low
birth weight and size but not to gestational age [17,30].
The mechanism for this is not fully understood but may
be a result of arsenic-induced oxidative stress resulting
in placental insufficiency [31] or disruption of the endo-
crine control of glucose homeostasis and cellular growthFigure 3 Pressure-volume curve during inflation to Prs = 20 cmH2O a
in male and female two week old C57BL/6 offspring exposed in utero
(mean ± SD). The maximum TGV reached during inflation was lower in m
There was no effect of 100μg/L arsenic on maximum TGV in two week fem[32,33]. Being small for gestational age can induce
alterations in metabolism, hormonal output and distri-
bution of cardiac output, and have a lifelong impact on
the potential for development and survival [34,35].
Foetal growth restriction is associated with increased
respiratory morbidity during early childhood [21,22,36]
and children who are small for gestational age are more
likely to be hospitalised for respiratory tract infections
[37,38]. Low birth weight is significantly associated with
worse lung function in adulthood and increased mortal-
ity from obstructive lung disease [20,24]. There are clear
associations between maternal smoking during pregnancynd exhalation to functional residual capacity plotted against TGV
to drinking water containing 0 (control) or 100μg/L arsenic
ale offspring exposed to 100μg/L arsenic compared to male controls.
ale offspring (* indicates significantly different to controls).
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Figure 4 Volume dependence of airway resistance, tissue damping and tissue elastance during inflation to Prs = 20 cmH2O and
exhalation to functional residual capacity in two week old male (A, B, C) and female (D, E, F) offspring exposed in utero to drinking
water containing 0 (control) or 100μg/L arsenic (mean). Tissue damping and tissue elastance at Prs = 20 cmH2O were significantly higher in
male offspring exposed to 100μg/L arsenic compared to male controls. There was no effect of arsenic exposure on tissue mechanics in females
and no effect of arsenic on airway resistance in either sex (* indicates significantly different to controls).
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function [40] and increased respiratory infections in early
childhood [41]. Therefore, arsenic-induced intrauterine
growth restriction resulting in low birth weight infants
may play a significant role in the childhood morbidity andFigure 5 Tissue elastance at Prs = 0 cmH20 in two, four, six and eight
drinking water containing 0 (control), 10 or 100μg/L arsenic (mean). A
offspring were resolved at four, six and eight weeks of age (* indicates signincreased the susceptibility to obstructive lung disease
seen in arsenic exposed populations.
Despite the offspring exposed to 100μg/L arsenic being
smaller at birth, these mice were not smaller in weight or
length at two, four, six and eight weeks of age comparedweek old male and female C57BL/6 offspring exposed in utero to
rsenic-induced impairments to lung mechanics in male two week old
ificantly different to controls).
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et al. mice exposed to 10μg/L arsenic in utero had normal
birth weight, but did have deficits in body weight during
infancy compared with controls [19]. The low birth weight
offspring in our study displayed catch-up growth during
the first two weeks of life. There is evidence that infants
who demonstrate catch-up growth and show early and
complete recovery from intrauterine growth restriction
are at greatest risk for developing metabolic diseases [42].
Similarly, in low birth weight infants, weight gain during
infancy has been shown to be inversely related to lung
function in infancy [43], with one study finding that the
lowest lung function outcomes were seen in infants of
below average birth weight with above average postnatal
weight gain [44]. Therefore, despite showing no deficits in
body weight later in life, the catch-up growth shown in
the first two weeks of life may be related to intrauterine
stress and poorer outcomes later in life.
As well as altering the pattern of somatic growth, we have
shown that in utero exposure to low doses of arsenic
(10 and 100μg/L) had direct effects on lung development
in males resulting in deficits in lung function two weeks
after birth. The abnormalities that we detected were mostly
in the parenchymal tissue of the lungs in arsenic exposed
offspring. Both tissue elastance and tissue damping were
significantly higher in male mice exposed to arsenic
compared with male controls, indicative of increased
stiffness of the parenchymal lung tissue. When inflated to
Prs = 20 cmH2O, male offspring exposed to 100μg/L arsenic
reached a lower maximum TGV than controls signifying a
loss of lung compliance. These data suggest that intraute-
rine stress caused by arsenic exposure is hindering the
development of the distal airways and alveolar tissue in the
lungs. Animal models of early life arsenic exposure, that
included exposure post-natally, have shown both increased
smooth muscle actin in small airways [45], which would
increase the resistance of the small peripheral airways
(tissue damping), and increased expression of collagen and
elastin in the lung parenchyma [46], which would increase
tissue stiffness (tissue elastance). As it is well established
that sufficient nutrition in utero is essential for the healthy
development of the lungs [47,48], it is unclear from this
study whether the changes in lung mechanics in arsenic
exposed mice are a result of suboptimal nutrition during
development or a direct effect of arsenic itself.
In our study, male offspring were more susceptible to
the harmful effects of in utero arsenic exposure on the
lung than female offspring. While female mice showed
similar trends in deficits in lung mechanics as males, the
deficits were not statistically significant. Epidemiological
studies also indicate that males may be more susceptible
to the health effects of arsenic than females [8,49] which
has been attributed to the differences in the way females
metabolise arsenic [50]. When inorganic arsenic isingested, it is absorbed into the blood and transported to
the liver where it is reduced and sequentially methylated
to monomethylarsonate (MMA) and dimethylarsinate
(DMA) [51]. MMA is a highly toxic intermediate product
and levels of MMA in the urine correlate strongly with
levels of MMA found in the body [52]. DMA is a less toxic
end product of arsenic methylation and can also be identi-
fied in urine [50]. Females have been shown to metabolise
arsenic more efficiently than males, resulting in less MMA
and more DMA in the urine [50]. While it is still largely
unknown how the effects of arsenic manifest differently in
males and females, sex dependent differences in the me-
tabolism of arsenic may have contributed to the difference
in susceptibility seen in our study.
We found that in utero arsenic exposure alone did not
produce a lasting effect on respiratory mechanics, rather
the early life deficits recovered with age. This data has two
implications from a public health point perspective.
Firstly, early life alterations in lung development induced
by arsenic exposure may be recovered provided there is
access to uncontaminated water. Secondly, we postulate
that arsenic-induced impairments lung development may
increase the susceptibility to respiratory infections in early
life by inhibiting effective clearance of pathogens. This is
consistent with the observation that there are increased
respiratory infections in children exposed to arsenic-
contaminated drinking water in utero [18]. Infancy
represents a period of high susceptibility to respiratory
infections and other harmful environmental exposures.
The incidence of respiratory infections leading to bron-
chitis, pneumonia, or whooping cough in infancy has been
shown to reduce adult lung function and increase the risk
of mortality from obstructive lung disease [20]. Addition-
ally, animal studies have shown that arsenic compromises
the lung’s immune response to viral infections resulting in
greater viral load and higher mortality [53]. In humans,
early life exposure to arsenic (before age 10) had long
term effects on lung function outcomes in adults, with an
11.5% decrease in FEV1 and 12.2% decrease in forced vital
capacity (FVC) compared to unexposed adults [9]. It is
unclear, however, whether the deficits in long term lung
function were a result of the direct effects of arsenic on
the lung, or an effect of arsenic exacerbating the effects of
other respiratory infections or environmental exposures in
early life. Arsenic-induced alterations to somatic growth
and lung development in utero may result in individuals
being more susceptible to postnatal insults, and contribute
to long term alterations in lung function and disease risk.
Conclusions
We have shown that the lung is highly susceptible to the
adverse effects of arsenic during the in utero period of
lung development. Exposure to arsenic for a brief period
during gestation impaired in utero somatic growth and
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two weeks after birth (infancy). Alterations to lung func-
tion during infancy, a period of high susceptibility to re-
spiratory system insults, may contribute to the increased
susceptibility to respiratory infections and diseases in ar-
senic exposed populations. The deficits following expos-
ure to the current WHO ‘safe’ dose of arsenic highlights
the potency of arsenic toxicity and draws attention to
the need for ongoing review of regulations regarding safe
contaminant levels in community drinking supplies and
the particular susceptibility of children to arsenic.
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